Bestclinicabroad
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
Dr. Yoon Sung-Soo is a top hematologist in South Korea, widely respected for his expertise in blood cancers, particularly lymphoma and multiple myeloma. With two decades of clinical and academic experience, he is a prominent professor of internal medicine at Seoul National University College of Medicine and a leading clinician at Seoul National University Hospital. Dr. Yoon has significantly contributed to the field through groundbreaking clinical trials and cancer genome research. He is internationally recognized for his work with the International Cancer Genome Consortium (ICGC), where he leads the Korean team on multiple myeloma research under the ICGC-ARGO initiative. His global exposure, including a post-doctoral fellowship at MD Anderson Cancer Center, has further strengthened his reputation as one of the best hematologists in South Korea and a pioneer in precision hematology.
Price upon request
Dr. Yoon-Koo Kang is a famous oncologist in South Korea with over 30 years of expertise in the treatment of gastrointestinal cancers. Based at Asan Medical Center in Seoul, he is renowned for his pioneering work in anticancer therapies, especially for stomach cancer, liver cancer, and gastrointestinal stromal tumors. A graduate of Seoul National University, Dr. Kang completed his residency and fellowship at Seoul National University Hospital and further honed his research skills at the National Cancer Institute in the USA. His career includes leadership roles such as Chief of the Hematology/Oncology Division at Korea Cancer Center Hospital and President of the Korean Society of Oncology. Dr. Kang currently serves as a Professor of Oncology at Asan Medical Center and was honored with the 2023 Asan Award in Clinical Medicine for his groundbreaking research. Internationally respected and recognized in Marquis Who’s Who, Dr. Yoon-Koo Kang is considered one of the best oncologists in South Korea for gastrointestinal and hepatobiliary cancers.
Price upon request
Prof. Dr. Ahn Jin Seok is a top oncologist and hematologist in South Korea, with four decades of distinguished experience in treating complex cancers and blood disorders. Currently leading the Oncohematology Unit at Samsung Medical Center, Dr. Ahn is highly respected for his expertise in managing lung cancer, breast cancer, neuroblastoma, and Ewing’s sarcoma. A graduate of Seoul National University, where he also completed his specialization and fellowship, Dr. Ahn began his medical career with a strong academic foundation that shaped his approach to comprehensive cancer care. In addition to his clinical practice, he has served as an academic consultant and educator, mentoring future specialists in the field. His time at Severance Hospital further contributed to his development as one of Korea’s most experienced and famous figures in oncology. As a senior specialist, Prof. Dr. Ahn Jin Seok is widely recognized for his leadership, dedication, and contributions to advancing cancer treatment in Korea.
Price upon request
Prof. Dr. Wan Kyu Eo is a distinguished and highly experienced oncologist and hematologist in South Korea, with a medical career spanning over three decades. He currently serves as the Head of the Department of Oncology at Kyung Hee University Hospital at Gangdong, Seoul. Widely recognized as one of the top cancer specialists in Korea, Dr. Eo has extensive expertise in the diagnosis and treatment of various malignancies, including gastrointestinal cancer, breast cancer, brain tumors, kidney cancer, liver cancer, and hematologic disorders such as lymphomas and blood cancers. His leadership and dedication to clinical excellence have made him a respected figure in Korean oncology, with a strong commitment to advancing cancer care through research and global collaboration.
Price upon request
Prof. Dr. Jong Ho Won is one of the most prominent and experienced hemato-oncologists in South Korea, currently serving at Soonchunhyang University Hospital in Seoul. With a distinguished medical career spanning over 20 years, Dr. Won specializes in leukemia, multiple myeloma, malignant lymphoma, myelodysplastic syndrome, and stem cell transplantation. As the Chief of the Hematology-Oncology Section and Director of the Stem Cell Therapy Center, he has made groundbreaking contributions to oncohematology. His international experience includes postdoctoral research at Yale University School of Medicine, further strengthening his global credentials. Prof. Dr. Jong Ho Won’s clinical excellence and academic leadership have earned him recognition as one of the top onco-hematologists in South Korea.
Price upon request
South Korea is renowned for its advanced healthcare system, advanced medical technology, and highly skilled healthcare professionals. In the field of hematology and oncology, the country has gained international recognition for providing high-quality treatment for patients dealing with blood cancers, solid tumors, and various hematological disorders. With an increasing number of medical tourists seeking specialized treatments, South Korea’s medical infrastructure is well-prepared to accommodate international patients, offering world-class care in both public and private hospitals.
Hematologists-oncologists in South Korea follow internationally recognized clinical guidelines, ensuring that they provide evidence-based treatments according to the needs of each patient. The healthcare system in South Korea is governed by strict regulations that guarantee the highest levels of care and patient safety. South Korea’s advanced medical technology, such as advanced imaging equipment, innovative therapies, and minimally invasive procedures, plays a crucial role in improving patient outcomes.
The accessibility of treatment options, affordability compared to Western countries, and high success rates make South Korea a popular destination for medical tourists. Patients traveling abroad for care can expect to find compassionate and skilled healthcare providers who prioritize patient-centered care. Additionally, emotional and psychological support is readily available, as healthcare professionals in South Korea understand the mental and emotional strain that comes with a serious illness like cancer.
In conclusion, South Korea is a leading destination for hematology-oncology treatments, offering international patients access to world-class medical expertise, advanced technology, and a comprehensive approach to care.
The following are notable hematologists-oncologists in South Korea. These professionals are recognized for their expertise in the field and have extensive experience in managing a wide range of hematological and oncological conditions.
Doctor Name: Dr. Jung Hee Seok, MD
Specialization: Hematology and Oncology
Years of Experience: 18 years
Dr. Jung specializes in the treatment of leukemia, lymphoma, and myeloma, utilizing advanced chemotherapy protocols, stem cell therapy, and targeted therapies. Dr. Jung is affiliated with Seoul National University Hospital, one of South Korea’s premier academic hospitals.
Dr. Kim Joo Young, MD
Specialization: Hematology and Oncology
Years of Experience: 22 years
Dr. Kim is an expert in solid tumor oncology, particularly gastrointestinal cancers, and offers personalized cancer care that includes immunotherapy and advanced radiation techniques. Dr. Kim works with the prestigious Samsung Medical Center.
Dr. Lee Sun Jin, MD
Specialization: Hematology and Oncology
Years of Experience: 15 years
Dr. Lee specializes in bone marrow disorders, including aplastic anemia and myelodysplastic syndromes. She employs a multidisciplinary approach, integrating the latest advancements in hematology and oncology. Dr. Lee practices at Asan Medical Center, a leading hospital in South Korea.
Dr. Park Min Seok, MD
Specialization: Hematology and Oncology
Years of Experience: 20 years
Dr. Park is focused on personalized treatments for hematological malignancies, particularly in the field of leukemia and lymphoma. He utilizes CAR-T cell therapy and other immunotherapy techniques. Dr. Park works at Yonsei Severance Hospital, known for its excellent oncology services.
| Consultations | Cost |
| Consultation with Hematologists | $200 - $300 |
Note: Costs are approximate and provided for general guidance only. Prices vary depending on the healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. Final fees are determined by the provider after an individual clinical assessment and may be affected by currency fluctuations.
Choosing to seek specialized hematology-oncology care abroad can feel overwhelming, especially with the emotional and physical challenges of battling a serious illness. South Korea offers a healthcare environment that is both advanced and compassionate, making it an excellent choice for patients seeking top-tier medical care.
Here are some reasons why South Korea is a leading destination for hematology and oncology care:
➤ Specialist training pathways and board certification standards: Doctors in South Korea undergo rigorous training, with many receiving education from prestigious medical institutions both locally and internationally. Board-certified hematologists-oncologists adhere to global clinical standards.
➤ Use of evidence-based clinical guidelines and modern diagnostics: South Korean medical professionals follow international clinical guidelines, ensuring that each treatment plan is based on the latest medical research and evidence. They use the most up-to-date diagnostic tools, including advanced imaging technologies and genetic testing, to provide personalized care.
➤ Multidisciplinary care environments and regulated practice settings: The country’s hospitals are equipped with multidisciplinary teams, ensuring that all aspects of a patient’s careranging from chemotherapy to psychological support, are well-coordinated. South Korea’s strict healthcare regulations provide a safety net for patients.
➤ Emphasis on patient safety, documentation, and informed consent: Healthcare institutions in South Korea follow stringent protocols for patient safety, thorough documentation, and informed consent. Patients are given clear information about their diagnosis, treatment options, and potential risks.
Patients considering hematology and oncology care in South Korea can share their medical reports with Best Clinic Abroad to receive coordinated support, guidance on consultation options, and a clear starting point for treatment planning.
What are the most popular procedures for international patients?
International patients often seek treatments such as chemotherapy, stem cell therapy, targeted therapies, immunotherapy, and bone marrow transplants for various hematological and oncological conditions.
Are consultations available in English?
Yes, many hospitals and clinics in South Korea provide consultations in English, with the support of medical translators to ensure clear communication between patients and healthcare providers.
How long should I plan to stay in South Korea after surgery?
The length of stay after surgery varies depending on the type of treatment and recovery process. Typically, patients may need to stay for 7–14 days to ensure proper follow-up and recovery before traveling back home.
What is the process for medical tourism in South Korea?
The process involves initial consultations, followed by treatment planning and coordination of logistics, including travel and accommodation. Medical facilitators, like Best Clinic Abroad, can assist with the entire process, making it easier for international patients to navigate their journey.
Disclaimer
This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.
